Customize your experience
You decide what information you want to see on your Sanofi Campus
More about science
Choose a therapeutic area to find related scientific content
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
.svg 767w, /dam/jcr:614586a4-9d5b-4635-8e61-0cafde125c35/asthma%20(6).svg 1200w)
Asthma
Atopic Dermatitis
Cardiovascular
COPD
Diabetes
Eosinophilic Esophagitis
Multiple Sclerosis
.svg 767w, /dam/jcr:61a43d09-b3d3-48bb-ab3f-c46e493445f9/nasal%20(1).svg 1200w)
Nasal Polyps
Multiple Myeloma
Prurigo Nodularis
Rare Diseases
Vaccines
Latest trends
Explore the most popular scientific articles and videos among Campus Sanofi users
RSV
Understanding de-escalation in antiplatelet therapy
Single antiplatelet therapy Insights on earlier use
Management of antithrombotic therapy in patients with AF undergoing PCI
Rattle
Clopidogrel as the standard of care for elective PCI: Findings from the ALPHEUS
IMD burden among adolescents
N-PASS Handbook
Impact of Meningococcal vaccination (ACWY) in adolescents
About Type 2 Inflammation - Atopic Dermatitis
RSV History
Type 2 Inflammation in CRSwNP
Events
Stay up to date and register for the latest events and view webinar recordings
Diatour Programme
CardioRisk WebApp
GAED 2023
Venous Thromboembolism Burden
Sanofi Thrombosis Summit
Hypertension and CVD
Diatour Inquiry Form
World Diabetes Day
Ultimate Need for Intensification
KSUMC Aubagio experience
What is Epilepsy
Diabetes Guidelines in Ramadan
Support for your patients
Discover the selection of support materials for patients from different therapeutic areas
Hyperglycemia
Insulin titration and technology-based solutions
Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
Dose adjustment of insulins and other medications during Ramadan
Clinical and economic value of SOLIQUA - Pharmacist perspective
Sanofi in News
Discover headline news on how Sanofi is engaged with the medical community
Ministry of Health organizes "KiDS" program at Expo 2020 Dubai to promote diabetes awareness at schools
Sanofi signs multi-pronged partnership with Dasman Diabetes Institute to intensify diabetes prevention in Kuwait
Saudi Health Council, Sanofi partner to boost diabetes studies and research in the kingdom
Our Products
Amaryl®
Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.
Aprovel®
Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II used to Effectively control Hypertension to normal Rates.
Aubagio®
AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)
Clexane®
Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.
Dupixent®
Is a fully human monoclonal antibody with
multiple indications in different therapeutic
areas.
Lantus®
Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.
Lemtrada®
Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).
Plavix®
Clopidogrel is an inhibitor of platelet
aggregation administered orally and
indicated for Secondary prevention of
atherothrombotic events.
Sarclisa®
Isatuximab is an immunoglobulin G1 (IgG1) monoclonal antibody (mAb) for the treatment of adult patients with relapsed and refractory multiple myeloma in combined regimens.
Soliqua®
Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.
Tavanic®
Levofloxacin is used in adults for the treatment of infections. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.
Toujeo®
Insulin Glargine 300, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 6 years.
Zympass®
Combination of Rosuvastatin Calcium & Ezetimibe used as adjunct to diet for treatment of Primary Hypercholesterolemia or Homozygous Familial Hypercholesterolemia.
▼This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.
YOU WILL NOW BE LEAVING THE SITE
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.